PSTV
Plus Therapeutics IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$45.36M
P/E Ratio
0.31
EPS
$21.56
Beta
1.40
52W High
$23.50
52W Low
$2.90
50-Day MA
$5.75
200-Day MA
$10.68
Dividend Yield
—
Profit Margin
-230.20%
Forward P/E
0.97
PEG Ratio
2.45
About Plus Therapeutics Inc
Plus Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the development, manufacturing, and commercialization of treatments for patients with cancer and other diseases. The company is headquartered in Austin, Texas.
Fundamentals
| Revenue (TTM) | $5.18M |
| Gross Profit (TTM) | $-3.20M |
| EBITDA | $-18.49M |
| Operating Margin | -693.00% |
| Return on Equity | -522.00% |
| Return on Assets | -73.80% |
| Revenue/Share (TTM) | $1.12 |
| Book Value | $1.74 |
| Price-to-Book | 3.81 |
| Price-to-Sales (TTM) | 8.75 |
| EV/Revenue | 18.19 |
| EV/EBITDA | 29.14 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -2.90% |
| Shares Outstanding | $6.88M |
| Float | $6.33M |
| % Insiders | 1.45% |
| % Institutions | 17.57% |
Historical Volatility
HV 10-Day
102.78%
HV 20-Day
91.71%
HV 30-Day
101.21%
HV 60-Day
127.34%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($38.00 target)
1
Strong Buy3
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026